المؤلفون: Hanna GJ; Dana-Farber Cancer Institute, Center for Salivary and Rare Head and Neck Cancers, Boston, Massachusetts., Ahn MJ; Samsung Medical Center, Department of Hematology and Oncology, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Muzaffar J; Moffitt Cancer Center, Department of Head and Neck-Endocrine Oncology, Tampa, Florida., Keam B; Seoul National University Hospital, College of Medicine, Seoul, Republic of Korea., Bowles DW; Department of Medicine-Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Wong DJ; Department of Head and Neck Medical Oncology, University of California, Los Angeles (UCLA), Los Angeles, California., Ho AL; Department of Head and Neck Medical Oncology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York., Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Worden F; Rogel Cancer Center, Michigan Medicine at the University of Michigan, Ann Arbor, Michigan., Yun T; National Cancer Center, Goyang, Republic of Korea., Meng X; Elevar Therapeutics, Fort Lee, New Jersey., Van Tornout JM; Elevar Therapeutics, Fort Lee, New Jersey., Conlan MG; Elevar Therapeutics, Fort Lee, New Jersey., Kang H; Department of Oncology University of California, San Francisco (UCSF), San Francisco, California.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Nov 14; Vol. 29 (22), pp. 4555-4563.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/adverse effects , Carcinoma, Adenoid Cystic*/drug therapy , Carcinoma, Adenoid Cystic*/pathology, Humans ; Vascular Endothelial Growth Factor A ; Vascular Endothelial Growth Factor Receptor-2 ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology

المؤلفون: Noel MS; Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA., Kim S; TYME Technologies Inc., Bedminster, New Jersey, USA., Hartley ML; The Ruesch Center for the Cure of Gastrointestinal Cancers, Washington, District of Columbia, USA., Wong S; Sarcoma Oncology Research Center, Santa Monica, California, USA., Picozzi VJ; Virginia Mason Hospital and Medical Center, Seattle, Washington, USA., Staszewski H; Mather Hospital, Port Jefferson, New York, USA., Kim DW; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Van Tornout JM; TYME Technologies Inc., Bedminster, New Jersey, USA., Philip PA; Karmanos Cancer Center, Wayne State University, Michigan, Detroit, USA.; SWOG, Farmington Hills, Michigan, USA., Chung V; City of Hope, Duarte, California, USA., Ocean AJ; Weill Cornell Medicine, New York-Presbyterian Hospital, New York, New York, USA., Wang-Gillam A; Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.

المصدر: Cancer medicine [Cancer Med] 2022 Nov; Vol. 11 (22), pp. 4169-4181. Date of Electronic Publication: 2022 May 02.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms*/pathology , Adenocarcinoma*/pathology, Humans ; Methoxsalen/therapeutic use ; Phenytoin/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Sirolimus/adverse effects ; Quality of Life ; Pancreatic Neoplasms

المؤلفون: Mateo J; Drug Development Unit; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London SM2 5PT, UK., Olmos D; Drug Development Unit; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London SM2 5PT, UK.; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain., Dumez H; Department of Oncology, University Hospitals Leuven and KU Leuven, Leuven B-3000, Belgium., Poondru S; Astellas Pharma Global Development, Northbrook, IL 60201, USA., Samberg NL; Astellas Pharma Global Development, Northbrook, IL 60201, USA., Barr S; Astellas Pharma Global Development, Northbrook, IL 60201, USA., Van Tornout JM; Astellas Pharma Global Development, Northbrook, IL 60201, USA., Jie F; Astellas Pharma Global Development, Northbrook, IL 60201, USA., Sandhu S; Drug Development Unit; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London SM2 5PT, UK., Tan DS; Drug Development Unit; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London SM2 5PT, UK., Moreno V; Drug Development Unit; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London SM2 5PT, UK., LoRusso PM; Yale University, New Haven, CT 06520, USA., Kaye SB; Drug Development Unit; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London SM2 5PT, UK., Schöffski P; Department of Oncology, University Hospitals Leuven and KU Leuven, Leuven B-3000, Belgium.

المصدر: British journal of cancer [Br J Cancer] 2016 Apr 12; Vol. 114 (8), pp. 889-96. Date of Electronic Publication: 2016 Mar 22.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Imidazoles/*therapeutic use , Multiprotein Complexes/*antagonists & inhibitors , Neoplasms/*drug therapy , Protein Kinase Inhibitors/*therapeutic use , TOR Serine-Threonine Kinases/*antagonists & inhibitors , Triazines/*therapeutic use, Adult ; Aged ; Dose-Response Relationship, Drug ; Female ; Half-Life ; Humans ; Imidazoles/pharmacokinetics ; Leukocytes, Mononuclear/drug effects ; Male ; Maximum Tolerated Dose ; Mechanistic Target of Rapamycin Complex 1 ; Mechanistic Target of Rapamycin Complex 2 ; Middle Aged ; Neoplasms/pathology ; Protein Kinase Inhibitors/pharmacokinetics ; Triazines/pharmacokinetics ; Young Adult

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Cortes J; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA. jcortes@mdanderson.org, Kim DW, Raffoux E, Martinelli G, Ritchie E, Roy L, Coutre S, Corm S, Hamerschlak N, Tang JL, Hochhaus A, Khoury HJ, Brümmendorf TH, Michallet M, Rege-Cambrin G, Gambacorti-Passerini C, Radich JP, Ernst T, Zhu C, Van Tornout JM, Talpaz M

المصدر: Leukemia [Leukemia] 2008 Dec; Vol. 22 (12), pp. 2176-83. Date of Electronic Publication: 2008 Aug 28.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Blast Crisis/*drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*pathology , Protein Kinase Inhibitors/*administration & dosage , Pyrimidines/*administration & dosage , Thiazoles/*administration & dosage, Administration, Oral ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents ; Benzamides ; Combined Modality Therapy ; Dasatinib ; Disease-Free Survival ; Drug Resistance, Neoplasm ; Female ; Genes, abl/genetics ; Hematopoietic Stem Cell Transplantation ; Humans ; Imatinib Mesylate ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics ; Male ; Middle Aged ; Piperazines ; Protein Kinase Inhibitors/adverse effects ; Pyrimidines/adverse effects ; Thiazoles/adverse effects ; Treatment Outcome ; Young Adult

المؤلفون: Sainz J; Department of Radiology, Childrens Hospital Los Angeles, California 90027, USA., Van Tornout JM, Sayre J, Kaufman F, Gilsanz V

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 1999 Mar; Vol. 84 (3), pp. 853-5.

نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Print ISSN: 0021-972X (Print) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Bone Density/*physiology , Collagen/*genetics , Polymorphism, Genetic/*physiology, Aging/physiology ; Anthropometry ; Child ; Child Development/physiology ; Female ; Genotype ; Humans ; Lumbar Vertebrae/diagnostic imaging ; Lumbar Vertebrae/physiology ; Tomography, X-Ray Computed

المؤلفون: Sainz J; Department of Radiology, Children's Hospital of Los Angeles, CA 90027, USA., Van Tornout JM, Loro ML, Sayre J, Roe TF, Gilsanz V

المصدر: The New England journal of medicine [N Engl J Med] 1997 Jul 10; Vol. 337 (2), pp. 77-82.

نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Print ISSN: 0028-4793 (Print) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Bone Density/*genetics , Mexican Americans/*genetics , Receptors, Calcitriol/*genetics, Alleles ; Child ; Female ; Femur/physiology ; Genotype ; Humans ; Polymorphism, Genetic ; Spine/physiology ; Tomography, X-Ray Computed

المؤلفون: Van Tornout JM; Department of Pediatrics, JSC/Norris Comprehensive Cancer Center, University of Southern California School of Medicine, Los Angeles 90033-0800, USA. vantorno@hsc.usc.edu, Spruck CH 3rd, Shibata A, Schmutte C, Gonzalez-Zulueta M, Nichols PW, Chandrasoma PT, Yu MC, Jones PA

المصدر: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 1997 Jul; Vol. 6 (7), pp. 493-7.

نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model: Print Cited Medium: Print ISSN: 1055-9965 (Print) Linking ISSN: 10559965 NLM ISO Abbreviation: Cancer Epidemiol Biomarkers Prev Subsets: MEDLINE

مواضيع طبية MeSH: Mutation*, Ethnicity/*statistics & numerical data , Nasopharyngeal Neoplasms/*epidemiology , Tumor Suppressor Protein p53/*genetics , Urban Population/*statistics & numerical data, Adolescent ; Adult ; Aged ; Causality ; DNA Mutational Analysis ; Ethnicity/genetics ; Female ; Humans ; Los Angeles/epidemiology ; Male ; Middle Aged ; Nasopharyngeal Neoplasms/genetics ; Risk

المؤلفون: Van Tornout JM; Department of Pediatrics, University of Southern California School of Medicine, Los Angeles, USA., Buckley JD, Quinn JJ, Feusner JH, Krailo MD, King DR, Hammond GD, Ortega JA

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 1997 Mar; Vol. 15 (3), pp. 1190-7.

نوع المنشور: Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Print ISSN: 0732-183X (Print) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Hepatoblastoma/*blood , Liver Neoplasms/*blood , Neoplasm Proteins/*metabolism , alpha-Fetoproteins/*metabolism, Child ; Child, Preschool ; Feasibility Studies ; Female ; Hepatoblastoma/drug therapy ; Hepatoblastoma/surgery ; Humans ; Infant ; Liver Neoplasms/drug therapy ; Liver Neoplasms/surgery ; Male ; Pilot Projects ; Prognosis ; Prospective Studies ; Retrospective Studies ; Time Factors ; Treatment Outcome

المؤلفون: Gonzalez-Zulueta M; Urological Research Laboratory, USC/Norris Comprehensive Cancer Center, Los Angeles, CA 90033, USA., Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA

المصدر: Cancer research [Cancer Res] 1995 Oct 15; Vol. 55 (20), pp. 4531-5.

نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Print ISSN: 0008-5472 (Print) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Cell Cycle Proteins* , CpG Islands* , Gene Expression Regulation, Neoplastic* , Genes, Tumor Suppressor* , Tumor Suppressor Proteins*, Carrier Proteins/*genetics, Base Sequence ; Chromosomes, Human, Pair 9 ; Colonic Neoplasms/genetics ; Cyclin-Dependent Kinase Inhibitor p15 ; Cyclin-Dependent Kinase Inhibitor p16 ; DNA Primers/chemistry ; DNA, Neoplasm/genetics ; Exons ; Genes ; Humans ; Methylation ; Molecular Sequence Data ; RNA, Neoplasm/genetics ; Transcription, Genetic ; Tumor Cells, Cultured ; Urinary Bladder Neoplasms/genetics